For Licensed Providers
Treating the core not the symptoms. LathMized is the only NAD+ protocol proven to work intracellularly with published results across 87+ biomarkers.
History of NAD
Scientists have been working with the NAD molecule since 1906. Historically, science has struggled to accomplish the three equations that need to be solved for optimal absorption and utilization in restoring depleted NAD+ levels.
UNTIL NOW…
Most NAD+ products ie; IV, tablets and compounded Sub Q remain extracellular with minimal cell penetration quickly degrading after administration. They treat symptoms.
LathMized NAD+ gets into the cell itself safely and effectively without needles — penetrating the spine within 15 minutes.
No refrigeration or concern for potency. A powder that dissolves in water instantly, administered by swishing in the mouth for 60–90 seconds, absorbed through the oral mucosa of the mouth in under 4 minutes.
+52.9%
Intracellular NAD+
increase observed
Within first 5 days
100%
Subject response
rate in testing
All subjects showed increase
87+
Biomarkers tracked
per patient
CLIA-certified testing
2 yr+
Molecule stability
shelf life
LathMized technology
Double blind documented study shows a 52.9% increase in intracellular NAD+ levels within the first five days of use. Designed for rapid cellular repletion directly where your patients need it most.
500mg dissolves instantly in less than 4 ounces of water. Swished in the mouth for 60–90 seconds where it absorbs through the oral mucosa — bypassing the gut — then simply swallowed.
No needles — No IV lines — No refrigeration.
Proprietary LathMized technology stabilizes the molecule for a 2+ year shelf life-addressing one of the primary challenges in NAD+ supplementation. No special storage — No cold chain — No complicated logistics.
Every patient completes a consultation prior to use, ensuring the protocol is integrated into a professional, biometrically informed care plan. You remain in full control of the clinical relationship from start to finish.
All other NAD+ and peptides treat the symptom. This treats the core.
IVs, injectables, and most oral NAD+ products work extracellularly. They never fully reach the cell with any staying power.
LathMized delivers BIOACTIVE-BIOAVAILABLE intracellular NAD — directly supporting the mitochondria where energy production and cellular repair actually happen.
This is the difference between treating symptoms versus treating the source.
*Based on internal testing data. Full clinical deck with methodology available upon registration.
A 58-year old female presented with a post-surgical wound that wouldn’t heal due to a condition that prevents regular wound closure and was severely infected. Despite standard wound care-healing was stalled.
LathMized™ NAD⁺ introduced Day 1
LathMized NAD+ accelerated wound closure-reduced inflammation-supported structural tissue regeneration. Healing progressed in 22 days-compared to prolonged course expected under standard care alone.
You order directly from us — set your own retail pricing — product ships straight to your office.
No middlemen — No complicated logistics — No cold chain.
1
Register at the link below with your credentials. You'll automatically receive the clinical deck and our team will follow up to connect.
2
Place your order via a simple payment link. Product ships directly to your practice with a 2+ year shelf life. No refrigeration — No complications.
3
Set your own retail pricing and integrate the protocol into your practice. Each patient gets a clinician-directed experience you fully control.
As intracellular NAD+ levels are restored, patients consistently notice improvement across four areas.
These shifts mark the transition from loading to maintenance dosing.
Sleep Quality
Often the first signal as cellular repair processes begin functioning at optimal levels — patients experience more restorative sleep — one of the earliest and most consistent indicators that NAD+ levels are rising intracellularly.
Reduced Brain Fog
As intracellular NAD+ levels normalize, patients report cognitive clarity returning — sharper thinking, faster processing and a notable reduction in mental fatigue throughout the day. Reduced brain fog is one of the most consistently reported outcomes during the loading phase.
Sustained Energy
Not a stimulant effect. The energy increase comes from cells generating ATP more efficiently at the mitochondrial level. Patients describe it as energy that is steady and lasting rather than the peaks and crashes of caffeine or other interventions.
Mental Execution
Beyond clarity, patients notice improved ability to follow through — better focus under pressure, improved working memory and the capacity to stay mentally engaged for longer periods. Particularly notable in high-cognitive-demand patients.
The loading phase is complete when these signals appear consistently. At that point patients transition to maintenance dosing — a lower, ongoing dose to sustain intracellular NAD+ levels indefinitely. Your clinical deck includes full protocol guidance.
Ready to Get Started?
Register to receive the full clinical deck with testing methodology — biomarker data across 87+ markers — protocol details — ordering information. Treating the core — not the symptoms-starts here.